Saldívar-Cerón, H.I.; Vargas-Camacho, J.A.; León-Cabrera, S.; Briseño-Díaz, P.; Castañeda-Ramírez, A.E.; Muciño-Galicia, A.E.; Díaz-Domínguez, M.R.
Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies. Sci. Pharm. 2025, 93, 26.
https://doi.org/10.3390/scipharm93020026
AMA Style
Saldívar-Cerón HI, Vargas-Camacho JA, León-Cabrera S, Briseño-Díaz P, Castañeda-Ramírez AE, Muciño-Galicia AE, Díaz-Domínguez MR.
Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies. Scientia Pharmaceutica. 2025; 93(2):26.
https://doi.org/10.3390/scipharm93020026
Chicago/Turabian Style
Saldívar-Cerón, Héctor Iván, Jorge Arturo Vargas-Camacho, Sonia León-Cabrera, Paola Briseño-Díaz, Ari Evelyn Castañeda-Ramírez, Axel Eduardo Muciño-Galicia, and María Regina Díaz-Domínguez.
2025. "Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies" Scientia Pharmaceutica 93, no. 2: 26.
https://doi.org/10.3390/scipharm93020026
APA Style
Saldívar-Cerón, H. I., Vargas-Camacho, J. A., León-Cabrera, S., Briseño-Díaz, P., Castañeda-Ramírez, A. E., Muciño-Galicia, A. E., & Díaz-Domínguez, M. R.
(2025). Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies. Scientia Pharmaceutica, 93(2), 26.
https://doi.org/10.3390/scipharm93020026
